Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes

BACKGROUND: Reports on the effects of renin–angiotensin–aldosterone system (RAAS) inhibitors on the clinical outcomes of coronavirus disease-19 (COVID-19) have been conflicting. We performed this meta-analysis to find conclusive evidence. METHODS: We searched published articles through PubMed, EMBAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bezabih, Yihienew M., Bezabih, Alemayehu, Alamneh, Endalkachew, Peterson, Gregory M., Bezabhe, Woldesellassie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178664/
https://www.ncbi.nlm.nih.gov/pubmed/34090358
http://dx.doi.org/10.1186/s12879-021-06088-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178664/
https://www.ncbi.nlm.nih.gov/pubmed/34090358
http://dx.doi.org/10.1186/s12879-021-06088-6

Ejemplares similares